Wilms' tumor screening: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
Line 7: Line 7:


==Screening==
==Screening==
'''Screening Children Predisposed to Wilms Tumor'''<ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq </ref>
* Screening can be very helpful to diagnose wilms tumor in high  risk patients.<ref name="pmid8095320">{{cite journal |vauthors=Green DM, Breslow NE, Beckwith JB, Norkool P |title=Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study |journal=Med. Pediatr. Oncol. |volume=21 |issue=3 |pages=188–92 |date=1993 |pmid=8095320 |doi= |url=}}</ref>
* High risk patients include:
** Children with Beckwith-Wiedemann syndrome
** Children with WAGR syndrome
* Screening is done with serial abdominal ultrasonography.<ref name="pmid28674120">{{cite journal |vauthors=Kalish JM, Doros L, Helman LJ, Hennekam RC, Kuiper RP, Maas SM, Maher ER, Nichols KE, Plon SE, Porter CC, Rednam S, Schultz KAP, States LJ, Tomlinson GE, Zelley K, Druley TE |title=Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma |journal=Clin. Cancer Res. |volume=23 |issue=13 |pages=e115–e122 |date=July 2017 |pmid=28674120 |doi=10.1158/1078-0432.CCR-17-0710 |url=}}</ref>  
* Serial abdominal ultrasonography is done as follows:
** Children suffering from beckwith-wiedemann syndrome:
*** Ultrasonography every three months until age seven years.
** Children suffering with WAGR and WT1-related syndromes:
*** Ultrasonography every three months until age five years
** Siblings of an individual with familial Wilms tumor:
*** Ultrasonography every three months until age eight years.
** Offspring of survivors of bilateral Wilms tumor:
*** Ultrasonography every three months until age eight years.


Children with a significantly increased predisposition to develop Wilms tumor (e.g., most children with [[Beckwith-Wiedemann syndrome]] or other overgrowth syndromes, [[WAGR syndrome]], [[Denys-Drash syndrome]], sporadic [[aniridia]], or isolated hemihyperplasia) are usually screened with ultrasound every 3 months at least until they reach age 8 years. Early-stage, asymptomatic, small Wilms tumors may be discovered and potentially removed with renal-sparing surgery.
=== '''Screening Children Predisposed to Wilms Tumor'''<ref name="cancergov">National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq </ref> ===
 
* Children with a significantly increased predisposition to develop Wilms tumor  
Tumor screening programs for each overgrowth syndrome have been suggested, based on published age and incidence of tumor type. Approximately 10% of patients with Beckwith-Wiedemann syndrome will develop a malignancy, with the most common being either Wilms tumor or hepatoblastoma, although adrenal tumors can also occur. Children with hemihyperplasia are also at risk for developing liver and adrenal tumors. Screening with abdominal ultrasound and serum [[alpha-fetoprotein]] is suggested until age 4 years. After age 4 years, most hepatoblastomas will have occurred, and imaging may be limited to renal ultrasound, which is quicker and does not require fasting before the exam.


Follow-up guidelines are available for patients with Beckwith-Wiedemann syndrome who have been molecularly subtyped.
Follow-up guidelines are available for patients with Beckwith-Wiedemann syndrome who have been molecularly subtyped.

Revision as of 20:00, 31 May 2018

Wilms' tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Wilms' Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wilms' tumor screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wilms' tumor screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wilms' tumor screening

CDC on Wilms' tumor screening

Wilms' tumor screening in the news

Blogs on Wilms' tumor screening

Directions to Hospitals Treating Wilms' tumor

Risk calculators and risk factors for Wilms' tumor screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

Children predisposed to wilms tumor should be screened earlier. The frequency of malformations observed in patients with Wilms tumor underlines the need for genetic counseling, molecular and genetic explorations, and follow-up.

Screening

  • Screening can be very helpful to diagnose wilms tumor in high risk patients.[1]
  • High risk patients include:
    • Children with Beckwith-Wiedemann syndrome
    • Children with WAGR syndrome
  • Screening is done with serial abdominal ultrasonography.[2]
  • Serial abdominal ultrasonography is done as follows:
    • Children suffering from beckwith-wiedemann syndrome:
      • Ultrasonography every three months until age seven years.
    • Children suffering with WAGR and WT1-related syndromes:
      • Ultrasonography every three months until age five years
    • Siblings of an individual with familial Wilms tumor:
      • Ultrasonography every three months until age eight years.
    • Offspring of survivors of bilateral Wilms tumor:
      • Ultrasonography every three months until age eight years.

Screening Children Predisposed to Wilms Tumor[3]

  • Children with a significantly increased predisposition to develop Wilms tumor

Follow-up guidelines are available for patients with Beckwith-Wiedemann syndrome who have been molecularly subtyped.

Newborns born with sporadic aniridia should undergo molecular testing for deletion analysis of PAX 6 and WT1. If a deletion of WT1 is observed, the child should be screened with ultrasound every 3 months until age 8 years, and the parents should be educated about the need to identify and treat early Wilms tumor.

Although the risk for Wilms tumor in the children of survivors of bilateral Wilms tumor is unknown and likely varies with the gene in which the mutation occurred, some experts recommend screening such children with serial ultrasound examinations every 3 months until age 8 years.

The risk of Wilms tumor in children with Klippel-Trénaunay syndrome (a unilateral limb overgrowth syndrome) was no different than the risk in the general population when assessed using the NWTS database. Routine ultrasound surveillance is not recommended.

Genetic counseling

The frequency of malformations observed in patients with Wilms tumor underlines the need for genetic counseling, molecular and genetic explorations, and follow-up.

A French study concluded that patients need to be referred for genetic counseling if they have one of the following:

One major abnormality such as:

  • Beckwith-Wiedemann symptoms (macroglossia, neonatal or postnatal macrosomia, abdominal wall defects, or visceromegaly); or

One condition such as:

Two or more minor malformations such as:

Simple oncological follow-up is indicated when there is no malformation or when there is only one minor malformation.

After genetic counseling takes place, a search for WT1 mutations should be considered for patients who have the following:

  • Bilateral Wilms tumor.
  • Familial Wilms tumor.
  • Wilms tumor and age younger than 6 months.
  • Genitourinary abnormality.
  • Mental retardation association.

A search for an 11p15 abnormality should be considered for patients exhibiting any symptoms of Beckwith-Wiedemann syndrome, hemihyperplasia, or bilateral or familial Wilms tumor.

References

  1. ↑ Green DM, Breslow NE, Beckwith JB, Norkool P (1993). "Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study". Med. Pediatr. Oncol. 21 (3): 188–92. PMID 8095320.
  2. ↑ Kalish JM, Doros L, Helman LJ, Hennekam RC, Kuiper RP, Maas SM, Maher ER, Nichols KE, Plon SE, Porter CC, Rednam S, Schultz K, States LJ, Tomlinson GE, Zelley K, Druley TE (July 2017). "Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma". Clin. Cancer Res. 23 (13): e115–e122. doi:10.1158/1078-0432.CCR-17-0710. PMID 28674120. Vancouver style error: initials (help)
  3. ↑ National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Wilms%27_tumor_screening&oldid=1473869"